23 May 2013
Keywords: abbott, begins, ph, trial, abt-560, danish, biopharmaceutical
Article | 06 August 2007
Danish biopharmaceutical firm NeuroSearch says that licensee US health care major Abbott Laboratories has enrolled and dosed the first patients
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 August 2007
30 July 2007
13 August 2007
© 2013 thepharmaletter.com